3282. Deputy Darren O'Rourke asked the Minister for Health the amount that the HSE spent under the high-tech drug scheme in 2025 and for the first six months of 2026, in tabular form. [55626/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.